I don’t have live access to current news feeds in this moment. Here’s what I can share based on reliable, historical context and public information up to now, and I can fetch current updates if you’d like me to search again.
-
Combigan is a prescription eye drop combining brimonidine and timolol used to lower intraocular pressure in glaucoma or ocular hypertension. It has been on the market since 2007 in the U.S. and has since been listed in various regions with updated labeling and SmPCs.
-
Recent highlights to look for if you’re checking latest news include: regulatory approvals, new labeling or safety warnings (e.g., contraindications, warnings about dry eye or corneal concerns), price changes, and availability or supply updates in different markets. For instance, SmPCs and prescribing information in major markets are periodically refreshed to reflect safety and usage considerations.
If you want, I can perform a fresh web search for the latest news on Combigan and summarize the top developments (FDA/other regulator actions, new study results, safety advisories, or formulation/brand changes) with direct citations. Would you like me to fetch current updates now?
Sources
Allergan, Inc. (NYSE:AGN) today announced that the U.S. Food and Drug Administration has approved COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, an alpha adrenergic receptor agonist with a beta adrenergic receptor inhibitor, for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. COMBIGAN(TM) is the newest addition to Allergan's...
www.ophthalmologyweb.comConsumer Medicine Information (CMI) about Combigan intended for persons living in Australia.
www.news-medical.netNews linked to Combigan (brimonidine tartrate/timolol maleate) by AbbVie
sigma.larvol.comDoctorOnCall offers the best prices on medications with same-day delivery. We sell genuine products with helpful dosage and usage information with unbeatable value for money.
www.doctoroncall.com.myCombigan (brimonidine/timolol) is a prescription eye drop that treats increased eye pressure. Learn about side effects, price, alternatives, dosage, and more.
www.medicalnewstoday.comWhen patients have progressed, don't compromise. COMBIGAN® delivers proven IOP- lowering power for patients in need of adjunctive or replacement therapy.
www.combigan.comCombigan 2 mg/ml + 5 mg/ml eye drops, solution - Summary of Product Characteristics (SmPC) by AbbVie Ltd
www.medicines.org.ukRegulators approved a new glaucoma treatment -- Combigan, an eye drop that treats the potentially blinding eye condition with two drugs that work through different mechanisms, Allergan Inc said Wednesday.
www.reuters.comAllergan, Inc. (NYSE:AGN) announced that the U.S. Food and Drug Administration has approved COMBIGAN™ (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%, an alpha adrenergic receptor agonist with a beta adrenergic receptor inhibitor, for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. COMBIGAN™ is the newest addition to Allergan's...
www.ophthalmologyweb.com